The Longitudinal Kinetics of AAV5 Vector Integration Profiles in Mice

被引：0
|
作者：
Ismail, Ashrafali Mohamed [1 ]
Witt, Evan [1 ]
Bouwman, Taren [1 ]
Clark, Wyatt [1 ]
Yates, Bridget [1 ]
Franco, Matteo [2 ,3 ]
Fong, Sylvia [1 ]
机构：
[1] BioMarin Pharmaceut Inc, Novato, CA USA
[2] ProtaGene CGT GmbH, Heidelberg, Germany
[3] ProtaGene US Inc, Burlington, MA USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
65
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [21] 新型重组AAV5/5载体及包装系统
    董小岩
    田文洪
    袁振华
    谭淑萍
    吴小兵
    生物工程学报, 2010, (05) : 679 - 686
  • [22] Optimization of elution conditions for immunoaffinity chromatography of AAV5 and AAV9 vectors
    Iurlova, E. V.
    Rebelin, M. S.
    Stukanev, V. K.
    Perepelkina, M. P.
    Gershovich, P. M.
    Madera, D. A.
    Karabelskii, A. V.
    Ivanov, R. A.
    Prokofyev, A. V.
    HUMAN GENE THERAPY, 2019, 30 (11) : A24 - A25
  • [23] A Longitudinal Study of Juvenile Methylmalonic Acidemia (MMA) Mice Treated by Target Integration of MMUT into Albumin with a Promoterless AAV Vector
    Venturoni, Leah E.
    Chandler, Randy J.
    Chau, Nelson
    Liao, Jing
    Gordo, Susan
    Kay, Mark
    Barzel, Adi
    Venditti, Charles
    MOLECULAR THERAPY, 2021, 29 (04) : 189 - 189
  • [24] Non-Canonical Amino Acid Incorporation into AAV5 Capsid Enhances Lung Transduction in Mice
    Chang, Hao
    Du, Ailing
    Ren, Lingzhi
    Liu, Nan
    Zhou, Xuntao
    Gao, Guangping
    Wang, Dan
    MOLECULAR THERAPY, 2023, 31 (04) : 552 - 553
  • [25] Positive and negative effects of adenovirus type 5 helper functions on adeno-associated virus type 5 (AAV5) protein accumulation govern AAV5 virus production
    Nayak, Ramnath
    Pintel, David J.
    JOURNAL OF VIROLOGY, 2007, 81 (05) : 2205 - 2212
  • [26] Formulation development and feasibility of AAV5 as a lyophilized drug product
    Vargas, Stephanie K.
    Shari, Farrokh
    Nambayan, Reinard
    Moshashaee, Saeed
    Siahaan, Teruna J.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 114 (02) : 1214 - 1223
  • [27] Packaging of Genomes Greater Than 5 Kb in Length into AAV5 Capsids Is Not Efficient Using a Common Vector Production Protocol
    Wu, Zhijian
    Yang, Hongyan
    Colosi, Peter
    MOLECULAR THERAPY, 2009, 17 : S39 - S39
  • [28] Immunoadsorption Plasmapheresis for the Removal of Plasma Immunoglobulins to Enable Repeat Dose Administration with an AAV5 Gene Therapy Vector
    Long, Brian R.
    Hock, Benjamin M.
    O'Neill, Charles A.
    Arens, Jeremy
    Seitel, Theresa
    Crockett, Lucy
    Relouzat, Francis
    Fovet, Claire-Maelle
    Dereuddre-Bosquet, Nathalie
    Maisonnasse, Pauline
    Letscher, Helene
    Le Grand, Roger
    Vettermann, Christian
    Gupta, Soumi
    MOLECULAR THERAPY, 2023, 31 (04) : 729 - 730
  • [29] Sites in the AAV5 capsid tolerant to deletions and tandem duplications
    Hida, Kaoru
    Won, Sang Y.
    Di Pasquale, Giovanni
    Hanes, Justin
    Chiorini, John A.
    Ostermeier, Marc
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2010, 496 (01) : 1 - 8
  • [30] Strategies for Upstream Transfection Optimization in AAV5 Manufacturing Processes
    Mccoy, Taylor
    MOLECULAR THERAPY, 2022, 30 (04) : 189 - 189
12345